SCH 33844 is a new non-sulfhydryl-containing angiotensin converting enzyme (ACE)
inhibitor. SCH 33844 diacid inhibited hydrolysis of the synthetic substrate hippuryl-histidyl …

SCH 33844 is a new, potent and long-acting inhibitor of angiotensin converting enzyme
(ACE). Antihypertensive, hemodynamic and autonomic actions of SCH 33844 were …

Summary SCH 31846, 1-(N-[1 (5)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl)-cis, syn-
octahydro-(H-indole-2-S)-carboxylic acid; CI-907; PD 109, 763–2, is a new non-sulfhydryl …

The antihypertensive activity of SCH 33844, a new angiotensin converting enzyme inhibitor,
was investigated in conscious spontaneously hypertensive rats during a 3-week treatment …

The antihypertensive, hemodynamic, and autonomic actions of SCH 31846, a new, potent
and long-acting non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor, were …

CI-907 is a new orally active nonsulfhydryl angiotensin converting enzyme (ACE) inhibitor.
Monoester (prodrug) and diacid forms produced concentration related ACE inhibition in …

Some in vitro and in vivo properties of CL 242,817, a new angiotensin l‐converting enzyme
(ACE) inhibitor, were studied and compared to those of captopril. In vitro CL 242,817 …

Abstract Spirapril (SCH 33844; 7-N-[l (S)-ethoxycarbonyl-3-phenylpropyl]-(S)-alanyl-l. 4-
dithia-7-azaspiro [4.4]-nonane-8 (S)-carboxylic acid) is a new angiotensin-converting …

Ceranapril (SQ 29,852) is a new inhibitor of angiotensin I (AI) converting enzyme (ACE)
belonging to the hydroxylphosphonate class. The purpose of the present report is to present …

Recent clinical data demonstrate that angiotensin converting enzyme (ACE) inhibitors
possess promising antihypertensive properties. We now report on the ACE inhibitory activity …